Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023

Seroprevalence studies on SARS-CoV-2 are essential for estimating actual prevalence rates of infection and vaccination in communities. This study evaluated infection rates based on total anti-nucleocapsid immunoglobulin (N) and/or infection history. We determined the seroprevalence of anti-receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Chansaenroj, Jira, Suntronwong, Nungruthai, Kanokudom, Sitthichai, Assawakosri, Suvichada, Vichaiwattana, Preeyaporn, Klinfueng, Sirapa, Wongsrisang, Lakana, Thongmee, Thanunrat, Aeemjinda, Ratchadawan, Khanarat, Nongkanok, Srimuan, Donchida, Thatsanathorn, Thaksaporn, Yorsaeng, Ritthideach, Katanyutanon, Apirat, Thanasopon, Wichai, Bhunyakitikorn, Wichan, Sonthichai, Chaninan, Angsuwatcharakorn, Piyada, Withaksabut, Withak, Wanlapakorn, Nasamon, Sudhinaraset, Natthinee, Poovorawan, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511501/
https://www.ncbi.nlm.nih.gov/pubmed/37730917
http://dx.doi.org/10.1038/s41598-023-42754-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511501/
https://www.ncbi.nlm.nih.gov/pubmed/37730917
http://dx.doi.org/10.1038/s41598-023-42754-2

Ejemplares similares